Samsung Epis Holdings Co., Ltd. (0126Z0.KS)
KSE · KRW · Healthcare · Biotechnology
₩311,000 (-2.05%) as of
Key statistics
- Market cap
- 7.72T
- Forward P/E
- 23.01
- Dividend yield
- 0.00%
- 52-week range
- 297,500.00 – 773,000.00
- Revenue (TTM)
- 1.51T
- Profit margin
- 33.90%
- Analyst target
- ₩566,666.7
- Volume
- 20.11k
About Samsung Epis Holdings Co., Ltd.
Samsung Epis Holdings Co., Ltd., a biotechnology company, manage the portfolio of biopharmaceutical products. The company was founded in 2025 and is based in Incheon, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Incheon, South Korea
- Employees
- 9
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.